Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid agencies to research and implement models for lowering the costs of prescription drugs. Separate provisions in the Inflation Reduction Act of 2022 also aimed at lower prescription drug costs are still in effect.

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower prescription costs — is befuddling drug pricing experts.

As President Donald Trump’s health care agenda for a second term takes shape, it’s becoming clear that many Biden-era policies won’t make the cut.

From being able to address patient questions to how this could impact your local pharmacy, there are still a lot of moving parts.

President Trump is rescinding Biden’s Executive Order on prescription drug costs. A change that could significantly affect Americans with chronic health conditions and fixed incomes.